Kijimea (SYNformulas GmbH)

Make probiotics the foundation of a longer, healthier life—for everyone. Since its founding in 2011, Kijimea’s founders, Dr. Clemens Fischer and Madlena Hohlefelder, have pursued an audacious vision: to improve lives through the power of science and probiotics—driven by deep passion and unwavering belief. What started in Munich has since become a global success story. Not only did Kijimea pioneer the leading product in the field of irritable bowel syndrome, but it has also grown into one of the world’s leading probiotic companies. Present in over 20 markets, we have helped transform the lives of more than 10 million people with our innovative, science-based probiotic products. In close collaboration with top institutions and scientists around the globe, we continue to unlock the hidden potential of the human microbiome—bringing it to life through groundbreaking products that make a real difference. Are you ready to shape the next chapter of healthcare? Then apply now and join our journey.